Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of O-Xylene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 3/20 | 0.91 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.53 |
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | CD44 | P16070 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| O-Xylene SCHEMBL7935899 | 1.00 | — | — | |
| O-Xylene SCHEMBL11483821 | 1.00 | TSHR (0.91) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL30211079 | 1.00 | TSHR (0.91) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL15021872 | 1.00 | TSHR (0.91) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL577140 | 1.00 | — | — | |
| O-Xylene SCHEMBL577139 | 1.00 | TSHR (0.91) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL3251065 | 1.00 | TSHR (0.91) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL3167517 | 0.96 | TSHR (0.83) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL27310124 | 0.96 | TSHR (0.83) | TSHRACHECYP3A4TDP1ALDH1A1 | |
| O-Xylene SCHEMBL27899298 | 0.96 | TSHR (0.83) | TSHRACHECYP3A4TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220390459-A1 | RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES | BECKMAN COULTER, INC. | 2022-12-08 | — | — | US | claimed |
| EP-4051670-A1 | RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES | Beckman Coulter, Inc. (US) | 2022-09-07 | — | — | EP | claimed |
| US-20210292551-A1 | THREE-DIMENSIONAL LATTICE STRUCTURES CONTAINING OPERATING MATERIAL, COMPOSITIONS COMPRISING THE SAME, AND COMPOSITIONS AND METHODS FOR MAKING THE SAME | BROWN JAMES F (US) | 2021-09-23 | — | — | US | claimed |
| CN-113195675-A | Thermal storage using phase change materials coated with nanoparticles | 盐储能技术公司 | 2021-07-30 | — | — | CN | claimed |
| EP-3830162-A1 | THREE-DIMENSIONAL LATTICE STRUCTURES CONTAINING OPERATING MATERIAL, COMPOSITIONS COMPRISING THE SAME, AND COMPOSITIONS AND METHODS FOR MAKING THE SAME | Brown, James F. (US) | 2021-06-09 | — | — | EP | claimed |
| WO-2020028136-A1 | THREE-DIMENSIONAL LATTICE STRUCTURES CONTAINING OPERATING MATERIAL, COMPOSITIONS COMPRISING THE SAME, AND COMPOSITIONS AND METHODS FOR MAKING THE SAME | BROWN JAMES F (US) | 2020-02-06 | — | — | WO | claimed |
| CN-110446537-A | Purification device for gas streams from isocyanate production | COVESTRO DEUTSCHLAND AG | 2019-11-12 | — | — | CN | claimed |
| US-10435543-B2 | Rubber or elastomer compositions and processes for their manufacturing | LEIBNIZ-INSTITUT FUER POLYMERFORSCHUNG DRESDEN E.V. (DE) | 2019-10-08 | — | — | US | claimed |
| CN-109824560-A | 1- cyclopropyl -3-(2- methyl mercapto -4- trifluoromethyl) propane-1,3-dione preparation method | 利尔化学股份有限公司 | 2019-05-31 | — | — | CN | claimed |
| CN-105576881-B | Electronic component mounted board and its manufacturing method, motor, air conditioner | 三菱电机株式会社 | 2019-03-05 | — | — | CN | claimed |
| EP-0863165-B1 | Method of producing conjugated diene polymers | JSR CORP (JP) | 2003-06-04 | — | — | EP | claimed |
| EP-1015442-B1 | PROCESS FOR PREPARING 3-ISOCHROMANONE | SYNGENTA LTD (GB) | 2003-04-16 | — | — | EP | claimed |
| US-20020143193-A1 | Process for preparing 3-isochromanone | SYNGENTA LIMITED (GB) | 2002-10-03 | — | — | US | claimed |
| EP-0714954-B1 | Cationic imidazoleazodyestuffs | CIBA SC HOLDING AG (CH) | 2002-09-25 | — | — | EP | claimed |
| EP-1000052-B1 | PROCESS FOR PREPARING 3-ISOCHROMANOME | SYNGENTA LTD (GB) | 2002-09-18 | — | — | EP | claimed |
| CN-1347508-A | Optical element, radiation image sensor and production method for optical element | HAMAMATSU PHOTONICS KK (JP) | 2002-05-01 | — | — | CN | claimed |
| US-6207840-B1 | CATALYTIC CARBONYLATION OF O-XYLENE-A,A'-DIHALIDE WITH CARBON MONOXIDE | ZENECA LIMITED (GB) | 2001-03-27 | — | — | US | claimed |
| US-6184392-B1 | REACTING AN ALPHA, ALPHA'-DIHALO-O-XYLENE WITH CARBON MONOXIDE AND WATER USING A METAL CATALYST WHILE MAINTAINING THE PH BETWEEN 7-11; SIMPLIFICATION BY ELIMINATING FINAL ACID TREATMENT; INTERMEDIATES OF FUNGICIDES, STROBILURINS | ZENECA LIMITED (GB) | 2001-02-06 | — | — | US | claimed |
| EP-0863165-A1 | Method of producing conjugated diene polymers | JSR Corporation (JP) | 1998-09-09 | — | — | EP | claimed |
| US-5708151-A | Cationic imidazole azo dyes | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-01-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143193-A1 | Process for preparing 3-isochromanone | IDH3A, IDH3B, ADH1C | ACHE 1140/4885CA2 2868/4885ESR1 4151/4885 |
| US-20220390459-A1 | RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES | DAXX, DDX41, PDE8B | ACHE 3386/4885CA2 1412/4885ESR1 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.